Coagulation, fibrinolytic system activation and endothelial dysfunction in patients with mitral stenosis and sinus rhythm

Angiology

Volumn 58, Issue 1, 2007, Pages 85-91

  Topaloglu, Serkan ^a   Boyaci, Ayca ^a   Ayaz, Selime ^a   Yilmaz, Sevinç ^a   Yanik, Oya ^b   Ozdemir, Ozcan ^a   Soylu, Mustafa ^a   Demir, Ahmet Duran ^a   Aras, Dursun ^a   Kisacik, Halil Lutfi ^a   Korkmaz, Sule ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOCYTE FACTOR 4; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBOLISM; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; MALE; MITRAL VALVE STENOSIS; PROTEIN BLOOD LEVEL; SINUS RHYTHM; THROMBOCYTE ACTIVATION;

ADULT; ANTITHROMBIN III; ATRIAL FIBRILLATION; BLOOD COAGULATION FACTORS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIUM, VASCULAR; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEART ATRIA; HUMANS; MALE; MITRAL VALVE STENOSIS; PULMONARY ARTERY;

EID: 33847020723     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706297917     Document Type: Article

References (18)

1. Wolf PA, Dawber TT, Thomas HE Jr, et al: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: Framingham Study. Neurology 28: 973-977, 1978.
2. Virchow RIK: Cellular Pathology as Based upon Physiological and Pathohistology, 7th Am Ed. (translated by Chance F, De Witt RM). New York: 1860, p 236-236.
3. Black IW, Chesterman CN, Hopkins AP, et al: Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 21: 451-457, 1993.
4. Mitusch R, Siemens HJ, Garbe M, et al: Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost 75: 219-223, 1996.
5. Fukuda Y, Nakamura K: The incidence of thromboembolism and the hemocoagulative background in patients with rheumatic heart disease. Jpn Circ J 48: 59-66, 1984.
6. Heppell RM, Berkin KE, McLeachan JM, et al: Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in nonrheumatic atrial fibrillation. Heart 77: 407-411, 1997.
7. Goldsmith I, Kumar P, Carter P, et al: Atrial endocardial changes in mitral valve disease: A scanning electron microscopy study. Am Heart J 140: 777-784, 2000.
8. Bonow RO, Carabello B, de Leon AC, et al: Guidelines for the management of patients with valvular heart disease. Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 98: 1949-1984, 1998.
9. Ileri M, Buyukasik Y, Ileri NS, et al: Activation of blood coagulation in patients with mitral stenosis and sinus rhythm. Am J Cardiol 81: 795-797, 1998.
10. Marin F, Roldan V, Monmeneu J, et al: Prothrombotic state and elevated plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation. Am J Cardiol 84: 862-864, 1999.
11. Lip GYH, Lowe GDO: Fibrin D-dimer: A useful clinical marker of thrombogenesis ? Clin Sci 89: 205-214, 1995.
12. Lip GYH, Lowe GDO: Increased markers of thrombo-genesis in chronic atrial fibrillation: Effect of warfarin therapy. Br Heart J 73: 527-533, 1995.
13. Jafri SM, Caceres L, Rosman HS, et al: Activation of the coagulation system in women with mitral stenosis and sinus rhythm. Am J Cardiol 70: 1217-1219, 1992.
14. Roldan V, Marin F, Marco P, et al: Hypofibrinolysis in atrial fibrillation. Am Heart J 136: 956-960, 1998.
15. Ridker PM, Hennekens CH, Stampfer MI, et al: Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 343: 940-943, 1994.
16. Penny WF, Weinstein M, Salzman EW, et al: Correlation of circulating vWF levels with cardiovascular hemodynamics. Circulation 83: 1630-1636, 1991.
17. Shinohara H, Fukuada N, Soeki T, et al: Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation. Jpn Heart J 39: 721-730, 1998.
18. Kunishima S, Hattori M, Kobayashi S, et al: Activation and destruction of platelets in patients with rheumatic heart disease. Eur Heart J 15: 335-338, 1994.